Design (Testphase)
Risk & Weakness
Downward Momentum
77
Findings
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Weak 3-month RS (≤ 10) and falling today — negative momentum.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(17)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Momentum
- The driving force behind a price trend: stocks that have recently risen sharply statistically tend to keep rising more often than not. Momentum strategies therefore buy strength - not perceived bargains.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Relative Strength (RS Rating)
- How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HYMC Hycroft Mining Holding Corporation | 07/29 | +212 % | 51 5/23 | Stage 1 | D 35 | 4 of 9 | 1.8 $ | Gold | Neutral | — | — | Basic Materials | 19.50 $ | -2.7 % | -6.3 % | +499.1 % | −62.7 % | +43.6 % | 97 | 42 | 8.2 % | 8.0 % | 2.72 | — | 0.0 | — | 8.6 | — | — | -0.8 | — | -405.6 % | 0.0 % | -86.1 % | -26.9 % | 0.00 | — | -100.0 % | — | 0.0 % | 0.0 % | 0.6 | 33.1 % | 23.2 % | 3.0 (1) |
| IBRX Immunitybio Inc | 08/04 | +57 % | 56 5/22 | Stage 2 | C 51 | 3 of 9 | 7.4 $ | Biotechnology | Uses AI | — | Healthcare | 7.20 $ | +269.7 % | +309.8 % | +191.5 % | −37.3 % | +77.1 % | 94 | 42 | 7.8 % | 7.0 % | 0.08 | — | 0.0 | 52.7 | — | — | — | -9.0 | -157.9 % | 99.3 % | 0.0 % | 0.0 % | -34.4 % | — | -134.5 % | +668.3 % | — | 0.0 % | 0.0 % | -23.1 | 17.6 % | 34.6 % | 4.6 (5) | |
| ZURA Zura Bio Limited Class A Ordinary Shares | 08/13 | -21 % | 42 4/22 | Stage 1 | D 32 | 3 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 5.40 $ | -17.8 % | +25.1 % | +287.9 % | −39.0 % | +207.4 % | 90 | 42 | 9.7 % | 8.0 % | -0.04 | — | 0.0 | — | — | — | — | -2.3 | — | — | 0.0 % | -41.0 % | -25.4 % | — | — | — | — | 0.0 % | 0.0 % | 23.1 | 78.6 % | 14.5 % | 4.6 (7) |
| RHLD Resolute Holdings Management, Inc. | 08/06 | — | — | Stage 1 | D 43 | 3 of 9 | 0.0 $ | Specialty Business Services | – | — | — | Industrials | 123.80 $ | -40.0 % | -36.8 % | +205.4 % | −47.1 % | — | 87 | 50 | 6.6 % | 6.5 % | — | 17.4 | 0.0 | — | 32.8 | — | — | 43.2 | — | 47.2 % | 7.7 % | 1.2 % | 2.2 % | 72.19 | — | +9.9 % | — | 0.0 % | 0.0 % | 3.7 | 47.7 % | 12.2 % | — |
| UAMY United States Antimony Corporation | 08/11 | +720 % | — | Stage 4 | D 38 | 1 of 9 | 0.0 $ | Other Industrial Metals & Mining | – | — | — | Basic Materials | 5.10 $ | +39.6 % | +9.6 % | +65.7 % | −65.2 % | +83.1 % | 78 | 50 | 8.1 % | 8.7 % | 0.35 | — | 78.1 | — | 7.1 | — | — | 14.7 | — | 22.1 % | -41.4 % | -19.7 % | -11.2 % | 0.00 | — | +162.8 % | — | 0.0 % | 0.0 % | 11.2 | 57.4 % | 22.0 % | — |
| RYAM Rayonier Advanced Materials | 08/04 | +32 % | 50 5/23 | Stage 1 | D 29 | 3 of 9 | 0.6 $ | Chemicals | – | — | — | Basic Materials | 8.90 $ | +37.0 % | +35.4 % | +133.1 % | −33.1 % | +57.3 % | 66 | 8 | 5.5 % | 4.7 % | 1.78 | — | 27.5 | 0.4 | 2.6 | — | 2.63 | 14.9 | — | 6.1 % | -32.8 % | -100.5 % | -0.1 % | 3.33 | — | -10.1 % | — | 0.0 % | 0.0 % | 3.7 | 80.6 % | 6.4 % | 4.0 (1) |
| OLMA Olema Pharmaceuticals Inc | 08/10 | -15 % | 28 3/22 | Stage 1 | D 25 | 2 of 9 | 1.0 $ | Biotechnology | – | — | — | Healthcare | 11.50 $ | -57.9 % | -55.6 % | +122.8 % | −68.5 % | +253.9 % | 54 | 42 | 7.7 % | 7.0 % | 2.01 | — | 0.0 | — | 2.0 | — | — | -3.3 | — | — | 0.0 % | -42.9 % | -25.5 % | 0.00 | — | — | — | 0.0 % | 0.0 % | 12.7 | 119.4 % | 21.0 % | 4.6 (8) |
| MAZE Maze Therapeutics, Inc. Common Stock | 08/11 | — | — | Stage 4 | E 23 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 26.90 $ | -36.3 % | -31.1 % | +82.5 % | −49.6 % | +131.5 % | 41 | 50 | 5.1 % | 5.1 % | — | — | 8.5 | — | 4.1 | — | — | 6.1 | — | 100.0 % | 0.0 % | -38.7 % | -22.3 % | 0.18 | — | -100.0 % | — | 0.0 % | 0.0 % | 7.5 | 95.6 % | 8.3 % | — |
| BTU Peabody Energy Corp | 07/30 | +7 % | 54 2/10 | Stage 4 | D 38 | 4 of 9 | 2.6 $ | Thermal Coal | – | — | — | Energy | 21.30 $ | -17.9 % | -24.0 % | +33.6 % | −42.4 % | +45.5 % | 37 | 11 | 4.3 % | 5.5 % | 0.37 | — | 24.7 | 0.7 | 0.7 | 21.6 | — | 10.2 | -4.7 % | 10.4 % | -4.6 % | -2.9 % | -1.5 % | 0.12 | 61.2 % | -8.9 % | — | 1.4 % | 27.5 % | 6.4 | 101.0 % | 14.4 % | 4.3 (6) |
| VGNT Versigent PLC | — | — | — | Stage 2 | D 42 | 4 of 9 | 0.0 $ | Auto Parts | – | — | — | Consumer Cyclical | 41.40 $ | — | — | — | −16.9 % | +15.3 % | 34 | 50 | 5.3 % | 5.7 % | — | — | 7.6 | — | — | — | — | 5.8 | 6.2 % | 12.0 % | 5.7 % | 30.6 % | 9.6 % | — | -1.0 % | +6.1 % | — | 0.0 % | 0.0 % | — | 48.6 % | — | — |
| LRMR Larimar Therapeutics Inc | 08/13 | +4 % | 89 8/22 | Stage 4 | D 34 | 2 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 3.80 $ | -3.4 % | -19.4 % | +10.4 % | −45.5 % | +278.9 % | 32 | 42 | 9.0 % | 7.4 % | 0.84 | — | 0.0 | — | — | — | — | -4.1 | — | — | 0.0 % | -109.8 % | -56.9 % | — | — | — | — | 0.0 % | 0.0 % | -1.1 | 85.7 % | 16.8 % | 4.9 (11) |
| TARA Protara Therapeutics Inc | 08/10 | +20 % | 94 9/22 | Stage 4 | D 34 | 2 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 3.90 $ | -25.0 % | -24.2 % | +26.5 % | −48.9 % | +564.3 % | 31 | 42 | 5.5 % | 6.2 % | 1.48 | — | 0.0 | — | 1.2 | — | — | 0.7 | — | — | 0.0 % | -37.3 % | -24.3 % | 0.02 | — | — | — | 0.0 % | 0.0 % | 17.8 | 82.4 % | 8.1 % | — |
| SYPR Sypris Solutions Inc | 08/11 | +9 % | 52 7/31 | Stage 1 | D 33 | 3 of 9 | 0.0 $ | Auto Parts | – | — | — | Consumer Cyclical | 1.90 $ | -2.5 % | +0.8 % | -1.1 % | −52.1 % | -44.9 % | 30 | 64 | 6.3 % | 8.9 % | 0.88 | — | 7.0 | 0.4 | 3.2 | — | 2.28 | 37.6 | — | 5.9 % | -8.2 % | -58.3 % | -6.2 % | 0.90 | — | -14.5 % | — | 0.0 % | 0.0 % | -0.3 | 19.9 % | 0.3 % | — |
| FBRX Forte Biosciences Inc | 08/13 | -23 % | 82 7/22 | Stage 1 | D 30 | 3 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 76.60 $ | -33.4 % | -22.3 % | +667.5 % | −47.7 % | -3.7 % | 26 | 42 | 7.7 % | 8.6 % | 2.84 | — | 0.0 | — | 10.2 | — | — | 1.9 | — | — | 0.0 % | -188.4 % | -83.9 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -10.3 | 74.8 % | 10.1 % | 5.0 (4) |
| VHC VirnetX Holding Corp Common Stock | 08/11 | +11 % | 62 6/25 | Stage 4 | D 31 | 2 of 9 | 0.1 $ | Software - Infrastructure | – | — | — | Technology | 13.00 $ | -26.1 % | -31.3 % | -10.9 % | −59.3 % | -75.6 % | 24 | 42 | 7.9 % | 9.2 % | 2.27 | — | 3.6 | 270.0 | 2.9 | — | 0.24 | 1.7 | — | 100.0 % | 0.0 % | -68.5 % | -33.8 % | — | — | +3,140.0 % | — | 0.0 % | 0.0 % | -22.9 | 13.1 % | 4.3 % | — |
| WLK Westlake Chemical Corporation | 08/04 | -9 % | 50 5/23 | Stage 1 | E 22 | 2 of 9 | 9.0 $ | Specialty Chemicals | – | — | — | Basic Materials | 70.50 $ | +4.6 % | +2.5 % | -8.7 % | −38.4 % | +36.2 % | 23 | 11 | 3.5 % | 3.1 % | 0.62 | — | 17.0 | 0.8 | — | — | 1.70 | 35.1 | -5.8 % | 6.3 % | -14.9 % | -16.0 % | -1.0 % | — | 43.4 % | -8.0 % | — | 3.0 % | 69.4 % | 6.0 | 35.2 % | 16.0 % | 3.8 (14) |
| ARVN Arvinas Inc | 08/05 | -23 % | 7 1/22 | Stage 4 | E 21 | 2 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 8.00 $ | -31.4 % | -31.9 % | +7.9 % | −44.7 % | +84.8 % | 23 | 42 | 5.5 % | 5.2 % | 1.75 | — | 17.9 | 5.8 | 1.3 | — | — | -1.6 | — | 134.5 % | -247.5 % | -42.3 % | -18.9 % | 0.02 | — | -0.3 % | — | 0.0 % | 0.0 % | -0.7 | 83.3 % | 7.2 % | 4.1 (21) |
| CATX Perspective Therapeutics Inc. | 08/12 | -19 % | 81 7/22 | Stage 1 | D 25 | 2 of 9 | 0.3 $ | Medical Devices | – | — | — | Healthcare | 2.90 $ | +9.1 % | +26.3 % | -24.2 % | −51.3 % | +346.0 % | 20 | 42 | 6.8 % | 6.5 % | 1.75 | — | 25.7 | 546.7 | 1.0 | — | — | -21.9 | — | -14,666.2 % | 0.0 % | -35.3 % | -20.3 % | 0.01 | — | -39.2 % | — | 0.0 % | 0.0 % | 8.2 | 76.7 % | 23.9 % | 4.6 (14) |
| ODYS Odysight.ai Inc. Common Stock | 08/12 | -18 % | 97 12/25 | Stage 1 | D 34 | 2 of 9 | 0.1 $ | Scientific & Technical Instruments | – | — | — | Technology | 4.20 $ | +21.5 % | +27.9 % | -9.4 % | −64.3 % | +48.5 % | 19 | 42 | 6.2 % | 7.5 % | -0.48 | — | 0.0 | 74.0 | 3.3 | — | — | -2.0 | — | 34.3 % | 0.0 % | -63.1 % | -36.7 % | 0.03 | — | -23.9 % | — | 0.0 % | 0.0 % | 1.1 | 25.8 % | 0.5 % | — |
| CMTL Comtech Telecommunications Corp | — | -29 % | 35 4/25 | Stage 1 | D 43 | 4 of 9 | 0.1 $ | Communication Equipment | – | — | — | Technology | 1.70 $ | -54.8 % | -54.1 % | -22.6 % | −67.0 % | +192.7 % | 18 | 95 | 14.2 % | 10.9 % | 1.50 | — | 5.3 | 0.1 | 1.0 | 3.3 | 0.66 | 8.8 | — | 33.0 % | -5.5 % | -9.1 % | 0.4 % | 0.96 | — | -7.6 % | — | 0.0 % | 0.0 % | 4.5 | 54.4 % | 0.8 % | — |
| PATK Patrick Industries Inc | 07/30 | +29 % | 21 4/31 | Stage 4 | C 50 | 4 of 9 | 2.7 $ | Recreational Vehicles | – | — | — | Consumer Cyclical | 82.60 $ | -18.9 % | -16.5 % | -13.7 % | −37.6 % | +32.2 % | 17 | 31 | 4.0 % | 3.7 % | 1.09 | 21.8 | 20.0 | 0.7 | 2.4 | 13.9 | 3.46 | 10.0 | 6.5 % | 23.1 % | 3.7 % | 11.7 % | 5.3 % | 1.35 | 36.9 % | +6.3 % | — | 2.3 % | 42.7 % | 6.7 | 112.4 % | 15.5 % | 4.0 (9) |
| SITE SiteOne Landscape Supply Inc | 07/29 | -11 % | 9 2/29 | Stage 4 | C 53 | 3 of 9 | 4.3 $ | Industrial Distribution | – | — | — | Industrials | 94.40 $ | -15.4 % | -9.9 % | -31.5 % | −31.8 % | +34.6 % | 16 | 73 | 4.4 % | 3.8 % | 1.34 | 27.9 | 20.9 | 0.9 | 2.6 | 17.3 | 2.52 | 13.1 | -2.8 % | 35.1 % | 3.4 % | 10.0 % | 4.6 % | 0.70 | 46.9 % | +3.6 % | — | 0.0 % | 0.0 % | 7.8 | 115.8 % | 7.9 % | 3.8 (11) |
| PRIM Primoris Services Corporation | 08/03 | +67 % | 36 5/29 | Stage 4 | C 51 | 3 of 9 | 5.8 $ | Engineering & Construction | – | — | — | Industrials | 84.40 $ | -31.5 % | -24.8 % | -10.1 % | −53.6 % | +51.1 % | 11 | 12 | 10.3 % | 8.2 % | 1.42 | 18.2 | 40.3 | 0.8 | 2.6 | 35.6 | 1.22 | 11.2 | 1.8 % | 10.4 % | 3.3 % | 15.9 % | 5.5 % | 1.12 | 40.0 % | +19.0 % | — | 0.4 % | 9.0 % | 6.3 | 105.1 % | 7.5 % | 4.6 (11) |
| G Genpact Limited | 08/06 | -6 % | 61 6/25 | Stage 4 | C 53 | 2 of 9 | 5.9 $ | Information Technology Services | – | — | — | Technology | 35.20 $ | -38.9 % | -41.5 % | -18.7 % | −43.1 % | +11.6 % | 9 | 64 | 4.4 % | 4.2 % | 0.62 | 11.1 | 18.3 | 1.1 | 2.5 | 9.0 | 1.16 | 7.4 | 15.4 % | 36.3 % | 11.0 % | 23.1 % | 9.2 % | 2.49 | 44.1 % | +6.6 % | — | 2.1 % | 24.5 % | 7.0 | 109.3 % | 10.5 % | 3.9 (11) |
| VSTM Verastem Inc | 08/06 | -17 % | 40 4/22 | Stage 4 | D 35 | 3 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 5.80 $ | -45.5 % | -51.5 % | -6.0 % | −69.3 % | +158.6 % | 9 | 42 | 8.6 % | 7.4 % | 0.29 | — | 0.0 | 10.3 | 6.8 | — | — | -0.2 | — | 85.1 % | 0.0 % | -786.2 % | -59.4 % | 1.05 | — | +209.1 % | — | 0.0 % | 0.0 % | -15.1 | 93.6 % | 23.0 % | 4.8 (9) |
| NIQ NIQ Global Intelligence plc | 08/13 | — | — | Stage 4 | C 49 | — | 0.0 $ | — | – | — | — | — | 11.20 $ | -50.9 % | -47.8 % | -39.4 % | −60.9 % | +81.4 % | 9 | 50 | 5.4 % | 5.7 % | — | — | 9.7 | — | — | — | — | 8.3 | — | — | 0.0 % | 0.0 % | 0.0 % | — | — | — | — | 0.0 % | 0.0 % | — | 0.0 % | — | — |
| CVRX CVRx Inc | 08/03 | -21 % | 89 8/22 | Stage 4 | D 37 | 3 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 5.20 $ | -27.5 % | -22.7 % | -35.0 % | −53.5 % | +112.7 % | 9 | 42 | 6.8 % | 7.0 % | 0.78 | — | 0.0 | 2.4 | — | — | — | -1.3 | — | 86.2 % | -89.1 % | -107.0 % | -27.3 % | — | — | +10.5 % | — | 0.0 % | 0.0 % | -13.5 | 63.6 % | 9.3 % | — |
| PTLO Portillo's Inc | 08/04 | -27 % | 21 4/31 | Stage 4 | C 46 | 3 of 9 | 0.3 $ | Restaurants | – | — | — | Consumer Cyclical | 4.60 $ | -10.6 % | +0.2 % | -54.1 % | −64.4 % | +36.4 % | 8 | 14 | 5.8 % | 5.3 % | 1.57 | — | 25.4 | 0.4 | — | — | — | 14.1 | — | 21.2 % | 2.1 % | 3.3 % | 1.8 % | — | — | +3.0 % | — | 0.0 % | 0.0 % | 3.4 | 76.4 % | 15.0 % | 4.1 (10) |
| BDTX Black Diamond Therapeutics Inc | 08/06 | -25 % | 16 2/22 | Stage 4 | E 20 | 1 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.70 $ | -33.7 % | -34.5 % | -36.5 % | −65.6 % | +479.8 % | 8 | 42 | 8.1 % | 9.6 % | 3.25 | — | 8.3 | — | 0.9 | — | — | 2.6 | — | — | 0.0 % | -35.2 % | -18.6 % | 0.17 | — | — | — | 0.0 % | 0.0 % | -1.1 | 78.6 % | 12.5 % | — |
| FKWL Franklin Wireless Corp | — | -9 % | 87 9/25 | Stage 4 | D 38 | 4 of 9 | 0.0 $ | Communication Equipment | – | — | — | Technology | 2.30 $ | -41.4 % | -36.5 % | -40.9 % | −53.8 % | +137.2 % | 8 | 88 | 3.7 % | 4.3 % | 0.27 | — | 27.2 | 0.8 | 0.8 | — | — | -10.4 | — | 19.3 % | -2.1 % | -2.2 % | -2.7 % | 0.03 | — | +49.7 % | — | 0.8 % | 0.0 % | 11.3 | 15.7 % | 0.3 % | — |
| PEPG PepGen Ltd | 08/06 | -31 % | 83 7/22 | Stage 4 | D 32 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.80 $ | -72.0 % | -69.2 % | +28.5 % | −78.1 % | +499.4 % | 8 | 42 | 7.6 % | 6.9 % | 1.88 | — | 0.0 | — | — | — | — | -3.1 | — | — | 0.0 % | -68.4 % | -35.8 % | — | — | — | — | 0.0 % | 0.0 % | 3.5 | 90.2 % | 7.9 % | — |
| PETS PetMed Express Inc | — | -29 % | 42 4/22 | Stage 4 | E 21 | 3 of 9 | 0.0 $ | Pharmaceutical Retailers | – | — | — | Healthcare | 2.00 $ | -42.8 % | -48.7 % | -37.5 % | −56.8 % | +21.5 % | 8 | 92 | 6.3 % | 5.9 % | 0.78 | — | 16.7 | 0.2 | — | — | 2.32 | 3.5 | — | 28.1 % | -32.0 % | -100.4 % | -15.4 % | — | — | -34.7 % | — | 0.0 % | 0.0 % | 1.5 | 44.8 % | 3.9 % | — |
| VTSI VirTra Inc | 08/10 | -19 % | 62 6/25 | Stage 4 | D 29 | 2 of 9 | 0.0 $ | Software - Application | – | — | — | Technology | 3.10 $ | -22.6 % | -28.6 % | -56.4 % | −58.1 % | +99.7 % | 8 | 5 | 4.4 % | 4.8 % | 0.73 | — | 22.0 | 2.1 | 0.8 | 100.0 | 0.69 | 14.5 | — | 64.9 % | -12.5 % | -5.1 % | -2.2 % | 0.17 | — | -15.0 % | — | 0.0 % | 0.0 % | 9.0 | 17.4 % | 0.7 % | — |
| COIN Coinbase Global Inc | 07/30 | +52 % | 12 2/22 | Stage 4 | D 44 | 3 of 9 | 40.2 $ | Financial Data & Stock Exchanges | – | — | — | Financial Services | 146.30 $ | -30.1 % | -36.7 % | -61.3 % | −68.0 % | +37.7 % | 7 | 94 | 6.3 % | 6.3 % | 3.35 | 56.4 | 107.5 | 6.4 | 3.0 | 15.1 | 1.40 | 30.7 | -7.1 % | 85.8 % | -16.3 % | 6.7 % | 1.1 % | 0.86 | 46.7 % | +9.4 % | — | 0.0 % | 0.0 % | 7.5 | 68.5 % | 11.4 % | 3.7 (29) |
| BLSH Bullish | — | — | — | Stage 4 | D 39 | 4 of 9 | 0.0 $ | Software - Infrastructure | – | — | — | Technology | 21.80 $ | -34.2 % | -44.7 % | — | −81.5 % | +110.5 % | 7 | 50 | 7.9 % | 6.9 % | — | — | 38.8 | — | 1.2 | — | — | 0.0 | — | 100.0 % | 0.0 % | -44.6 % | -10.4 % | 0.19 | — | -2.1 % | — | 0.0 % | 0.0 % | 9.0 | 24.5 % | 24.6 % | — |
| CNXC Concentrix Corporation | — | -23 % | 73 7/25 | Stage 4 | D 33 | 4 of 9 | 1.5 $ | Information Technology Services | – | — | — | Technology | 24.60 $ | -40.1 % | -38.1 % | -50.4 % | −63.8 % | +43.3 % | 6 | 9 | 7.0 % | 6.3 % | 0.45 | — | 2.2 | 0.2 | — | 3.1 | 0.32 | 11.1 | — | 34.5 % | -13.2 % | -38.9 % | 3.4 % | — | — | +2.2 % | — | 5.9 % | 13.5 % | 3.3 | 105.3 % | 21.1 % | 4.0 (6) |
| SERV Serve Robotics Inc. Common Stock | 08/06 | — | 37 5/29 | Stage 4 | C 52 | 3 of 9 | 0.4 $ | Specialty Industrial Machinery | Sells AI | — | Industrials | 4.80 $ | -38.2 % | -40.7 % | -53.1 % | −68.4 % | +284.4 % | 6 | 42 | 7.3 % | 7.3 % | 2.26 | — | 0.0 | 83.5 | — | — | — | 0.0 | — | -441.1 % | 0.0 % | -52.0 % | -32.8 % | — | — | +46.3 % | — | 0.0 % | 0.0 % | 16.0 | 44.9 % | 29.8 % | 5.0 (5) | |
| NUS Nu Skin Enterprises Inc | 08/06 | -27 % | 10 1/16 | Stage 4 | D 44 | 4 of 9 | 0.2 $ | Household & Personal Products | – | — | — | Consumer Defensive | 5.20 $ | -45.4 % | -46.7 % | -36.3 % | −66.2 % | +51.8 % | 6 | 2 | 5.0 % | 4.3 % | 0.96 | 5.1 | 5.0 | 0.2 | 0.3 | 5.8 | 0.78 | 2.5 | — | 69.3 % | 3.8 % | 7.0 % | 3.7 % | 0.35 | — | -14.3 % | — | 4.8 % | 20.0 % | 10.7 | 76.6 % | 7.6 % | — |
| TTEC TTEC Holdings Inc | 08/06 | -31 % | 81 8/25 | Stage 4 | D 25 | 4 of 9 | 0.1 $ | Information Technology Services | Sells AI | — | Technology | 2.50 $ | -41.7 % | -41.7 % | -50.0 % | −62.7 % | +94.2 % | 6 | 3 | 6.7 % | 6.9 % | 1.07 | — | 1.9 | 0.1 | — | 1.2 | 0.23 | 5.3 | — | 23.5 % | -9.6 % | -101.0 % | 3.7 % | — | — | -3.2 % | — | 0.0 % | 0.0 % | 5.0 | 31.5 % | 32.2 % | — | |
| RAIN Rain Enhancement Technologies Holdco, Inc. Class A Common Stock | 08/13 | — | 90 11/29 | Stage 4 | D 38 | 3 of 9 | 0.0 $ | Pollution & Treatment Controls | – | — | — | Industrials | 1.40 $ | -61.8 % | -68.0 % | -62.1 % | −76.5 % | — | 6 | 42 | 17.7 % | 14.8 % | -0.25 | — | 0.0 | — | — | — | — | 0.0 | — | -4,617.1 % | 0.0 % | 0.0 % | -275.8 % | — | — | — | — | 0.0 % | 0.0 % | -67.7 | 9.4 % | 0.8 % | — |
| LULU Lululemon Athletica Inc. | — | -24 % | 3 1/31 | Stage 4 | D 42 | 4 of 9 | 13.5 $ | Apparel Retail | – | — | — | Consumer Cyclical | 118.90 $ | -47.6 % | -45.7 % | -40.7 % | −55.6 % | +7.4 % | 5 | 19 | 4.4 % | 4.4 % | 0.88 | 10.1 | 10.7 | 1.2 | 2.8 | 10.6 | 0.91 | 5.5 | 11.2 % | 55.7 % | 13.0 % | 32.0 % | 16.1 % | 0.44 | 56.6 % | +4.9 % | — | 0.0 % | 0.0 % | 9.6 | 82.6 % | 9.2 % | 3.8 (36) |
| FMC FMC Corporation | 07/29 | -29 % | 86 8/23 | Stage 4 | D 25 | 1 of 9 | 1.4 $ | Agricultural Inputs | – | — | — | Basic Materials | 10.70 $ | -20.2 % | -12.5 % | -71.6 % | −74.7 % | +32.1 % | 5 | 7 | 6.0 % | 5.7 % | 0.39 | — | 7.1 | 0.4 | 0.7 | 6.8 | 1.55 | 35.1 | -0.5 % | 31.9 % | -84.8 % | -78.4 % | 0.6 % | 2.56 | 19.3 % | -18.3 % | — | 3.0 % | 38.7 % | 5.3 | 95.7 % | 28.7 % | 3.6 (20) |
| AKBA Akebia Therapeutics, Inc. | 08/06 | +3 % | 29 3/22 | Stage 4 | D 32 | 1 of 9 | 0.3 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 1.30 $ | -31.7 % | -34.7 % | -64.2 % | −74.5 % | +223.1 % | 5 | 42 | 7.0 % | 7.4 % | 0.24 | — | 28.7 | 1.5 | 14.0 | 5.7 | — | 66.9 | — | 81.9 % | -8.8 % | -79.0 % | 2.0 % | 0.46 | — | +47.5 % | — | 0.0 % | 0.0 % | -10.8 | 42.1 % | 7.2 % | 4.8 (4) |
| PEW GrabAGun Digital Holdings Inc. | 08/12 | — | 85 10/29 | Stage 4 | D 39 | 3 of 9 | 0.1 $ | Aerospace & Defense | Uses AI | — | — | Industrials | 2.50 $ | -19.9 % | -24.6 % | -61.4 % | −89.3 % | +194.8 % | 5 | 42 | 4.1 % | 4.9 % | -0.02 | — | 243.9 | 0.9 | — | — | — | 0.0 | — | 12.0 % | -4.5 % | -8.4 % | -3.8 % | — | — | +3.6 % | — | 0.0 % | 0.0 % | 12.3 | 25.6 % | 10.0 % | — |
| MSTR MicroStrategy Incorporated | 07/30 | +72 % | 10 2/25 | Stage 4 | D 25 | 4 of 9 | 35.2 $ | Software - Application | – | — | — | Technology | 93.30 $ | -31.7 % | -41.6 % | -76.8 % | −81.3 % | +183.3 % | 4 | 7 | 9.2 % | 7.7 % | 3.55 | — | 1.7 | 71.7 | 0.9 | — | 2.85 | 179.2 | -11,641.5 % | 67.6 % | 0.0 % | -30.8 % | -38.7 % | 0.18 | 84.1 % | +3.0 % | — | 0.0 % | 0.0 % | 6.9 | 64.0 % | 11.8 % | 4.3 (13) |
| SHAK Shake Shack Inc | 07/30 | -9 % | 81 10/31 | Stage 4 | C 53 | 4 of 9 | 2.8 $ | Restaurants | – | — | — | Consumer Cyclical | 62.80 $ | -33.3 % | -35.6 % | -47.9 % | −61.8 % | +25.5 % | 4 | 70 | 4.5 % | 5.1 % | 1.63 | 64.1 | 56.2 | 1.9 | 4.8 | 74.1 | 2.55 | 17.5 | -0.5 % | 40.4 % | 2.8 % | 8.5 % | 2.1 % | 1.78 | 27.4 % | +15.4 % | — | 0.0 % | 0.0 % | 4.6 | 107.8 % | 12.3 % | 3.7 (24) |
| WHR Whirlpool Corporation | 07/27 | -23 % | 43 6/31 | Stage 4 | D 33 | 2 of 9 | 2.4 $ | Furnishings, Fixtures & Appliances | – | — | — | Consumer Cyclical | 37.50 $ | -49.2 % | -46.6 % | -53.2 % | −66.3 % | +40.1 % | 4 | 19 | 5.9 % | 5.3 % | 1.14 | — | 45.2 | 0.2 | — | — | 1.04 | 8.7 | 1.3 % | 14.5 % | 1.1 % | 5.5 % | 2.1 % | — | 23.4 % | -6.5 % | — | 9.9 % | 68.0 % | 3.8 | 103.4 % | 0.2 % | 2.8 (12) |
| CMPX Compass Therapeutics Inc. | 08/10 | -12 % | 7 1/22 | Stage 4 | D 41 | 4 of 9 | 0.3 $ | Biotechnology | – | — | — | Healthcare | 1.90 $ | -61.6 % | -58.0 % | -35.7 % | −69.9 % | +347.4 % | 4 | 42 | 4.9 % | 6.6 % | 0.75 | — | 0.0 | — | 1.8 | — | — | -8.9 | — | — | 0.0 % | -46.0 % | -27.9 % | 0.05 | — | -100.0 % | — | 0.0 % | 0.0 % | 10.3 | 94.2 % | 26.1 % | 4.8 (9) |
| UPB Upstream Bio, Inc. | 08/05 | — | — | Stage 4 | D 33 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 6.30 $ | -76.7 % | -77.1 % | -58.8 % | −81.1 % | +501.4 % | 4 | 50 | 5.8 % | 6.4 % | — | — | 0.0 | — | 1.1 | — | — | 0.0 | — | 100.0 % | 0.0 % | -41.8 % | -27.8 % | 0.00 | — | +20.4 % | — | 0.0 % | 0.0 % | 25.0 | 89.5 % | 11.0 % | — |
| DCGO DocGo Inc | 08/06 | -32 % | 70 6/22 | Stage 4 | D 26 | 3 of 9 | 0.1 $ | Medical Care Facilities | – | — | — | Healthcare | 0.65 $ | -42.3 % | -43.6 % | -52.1 % | −74.2 % | +307.7 % | 4 | 58 | 10.1 % | 8.5 % | 1.02 | — | 60.2 | 0.2 | 0.5 | — | — | 5.6 | — | 30.4 % | -62.2 % | -97.8 % | -18.3 % | 0.22 | — | -47.7 % | — | 0.0 % | 0.0 % | -2.0 | 43.3 % | 4.7 % | — |
| NEOV NeoVolta Inc. Common Stock | 08/26 | -14 % | 76 9/29 | Stage 4 | C 53 | 4 of 9 | 0.1 $ | Electrical Equipment & Parts | – | — | — | Industrials | 2.10 $ | -29.6 % | -25.6 % | -55.5 % | −73.2 % | +318.8 % | 4 | 42 | 18.1 % | 16.8 % | -0.57 | — | 0.0 | 7.1 | 5.6 | — | — | -41.0 | — | 21.3 % | -63.4 % | -88.1 % | -37.4 % | 0.03 | — | +218.6 % | — | 0.0 % | 0.0 % | 7.6 | 19.2 % | 6.5 % | — |
| SER Serina Therapeutics Inc | 08/10 | -32 % | 30 3/22 | Stage 4 | D 31 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 2.00 $ | +0.4 % | -58.3 % | -63.9 % | −77.0 % | +422.0 % | 4 | 16 | 10.6 % | 9.9 % | 0.03 | — | 0.0 | 310.0 | 2.4 | — | — | 37.4 | — | -10,210.0 % | 0.0 % | -221.9 % | -89.8 % | 0.18 | — | +132.1 % | — | 0.0 % | 0.0 % | -3.6 | 9.8 % | 3.3 % | — |
| BRBR Bellring Brands LLC | 08/03 | -23 % | 65 4/16 | Stage 4 | D 37 | 2 of 9 | 1.3 $ | Packaged Foods | – | — | — | Consumer Defensive | 12.40 $ | -57.8 % | -58.9 % | -77.3 % | −81.1 % | +14.6 % | 3 | 18 | 8.3 % | 7.1 % | 0.52 | — | 8.8 | 0.6 | — | 7.0 | — | 8.3 | 11.2 % | 30.2 % | 6.8 % | 61.5 % | 18.5 % | — | -48.6 % | +16.1 % | — | 0.0 % | 0.0 % | 8.8 | 109.9 % | 14.5 % | 4.4 (17) |
| BUR Burford Capital Ltd | 08/06 | -22 % | 27 3/22 | Stage 4 | D 25 | 2 of 9 | 0.9 $ | Asset Management | – | — | — | Financial Services | 4.10 $ | -52.7 % | -55.4 % | -67.3 % | −72.9 % | +111.5 % | 3 | 80 | 5.6 % | 5.3 % | 1.08 | — | 9.7 | — | — | — | — | 15.8 | — | — | 0.0 % | -68.4 % | -17.2 % | — | — | -28.0 % | — | 3.0 % | 11.6 % | — | 78.3 % | 7.9 % | 5.0 (5) |
| FULC Fulcrum Therapeutics Inc | 08/04 | +8 % | 56 5/22 | Stage 4 | D 35 | 4 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 3.60 $ | -66.0 % | -68.9 % | -46.8 % | −77.1 % | +61.6 % | 3 | 42 | 6.4 % | 8.1 % | 3.00 | — | 0.0 | — | 0.8 | — | — | -3.1 | — | — | 0.0 % | -27.1 % | -18.4 % | 0.02 | — | -100.0 % | — | 0.0 % | 0.0 % | 28.2 | 116.3 % | 8.4 % | — |
| ACTU Actuate Therapeutics, Inc. Common stock | 08/13 | — | 29 3/22 | Stage 4 | D 29 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 1.10 $ | -68.5 % | -75.9 % | -84.7 % | −78.7 % | +409.1 % | 3 | 42 | 10.3 % | 12.5 % | — | — | 0.0 | — | 7.0 | — | — | 0.0 | — | — | 0.0 % | -553.8 % | -203.8 % | 0.11 | — | — | — | 0.0 % | 0.0 % | -56.3 | 58.2 % | 8.7 % | — |
| ATLN Atlantic International Corp. Common Stock | 08/12 | -33 % | 96 13/29 | Stage 4 | D 44 | 4 of 9 | 0.1 $ | Staffing & Employment Services | – | — | — | Industrials | 0.75 $ | +0.0 % | -70.5 % | -55.2 % | −80.2 % | +476.9 % | 3 | 42 | 32.0 % | 19.8 % | -2.95 | — | 0.0 | 0.1 | — | — | — | -1.1 | — | 9.6 % | -13.6 % | -390.0 % | -6.4 % | — | — | -1.5 % | — | 0.0 % | 0.0 % | -1.0 | 3.4 % | 2.6 % | — |
| BEAT Heartbeam Inc | 08/12 | -29 % | 16 2/22 | Stage 4 | D 39 | 2 of 9 | 0.0 $ | Health Information Services | – | — | — | Healthcare | 0.50 $ | -71.4 % | -74.8 % | -55.7 % | −84.0 % | +499.0 % | 3 | 42 | 8.8 % | 7.1 % | -0.83 | — | 0.0 | — | — | — | — | -3.0 | — | — | 0.0 % | -495.6 % | -195.1 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -100.6 | 9.3 % | 4.4 % | — |
| BTCS BTCS Inc | 08/12 | -20 % | 41 4/22 | Stage 4 | E 23 | 3 of 9 | 0.1 $ | Capital Markets | – | — | — | Financial Services | 1.00 $ | -59.5 % | -64.1 % | -77.2 % | −88.1 % | +395.0 % | 3 | 9 | 10.1 % | 8.6 % | 3.39 | — | 55.9 | 3.3 | 0.7 | — | — | 0.0 | — | 17.1 % | 0.0 % | -184.0 % | -5.7 % | 0.78 | — | +304.9 % | — | 4.5 % | 3.1 % | -1.6 | 22.0 % | 6.5 % | — |
| CELU Celularity Inc | — | -32 % | 57 5/22 | Stage 4 | D 28 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.64 $ | -37.0 % | -54.1 % | -80.6 % | −84.7 % | +273.1 % | 3 | 11 | 13.4 % | 11.3 % | 0.54 | — | 0.0 | 0.9 | — | — | — | -36.8 | — | 24.4 % | 0.0 % | -6,367.2 % | -30.9 % | — | — | -51.0 % | — | 0.0 % | 0.0 % | -35.6 | 12.8 % | 5.6 % | — |
| LCID Lucid Group Inc | 08/04 | -30 % | 33 5/31 | Stage 4 | D 44 | 1 of 9 | 2.9 $ | Auto Manufacturers | – | — | — | Consumer Cyclical | 7.40 $ | -50.9 % | -44.9 % | -70.0 % | −79.7 % | +12.2 % | 2 | 42 | 8.0 % | 7.4 % | 0.83 | — | 0.0 | 2.1 | 4.6 | — | — | -2.1 | — | -95.6 % | -239.8 % | -97.6 % | -28.2 % | 1.55 | — | +67.6 % | — | 0.0 % | 0.0 % | -6.5 | 61.9 % | 40.3 % | 2.9 (15) |
| BYRN Byrna Technologies Inc | 07/09 | +8 % | 24 4/29 | Stage 4 | C 52 | 4 of 9 | 0.1 $ | Aerospace & Defense | – | — | — | Industrials | 4.60 $ | -67.1 % | -64.2 % | -79.5 % | −83.6 % | +143.2 % | 2 | 13 | 7.5 % | 6.6 % | 1.79 | — | 41.0 | 0.9 | — | — | — | 11.3 | — | 60.3 % | 7.3 % | 14.3 % | 9.2 % | — | — | +37.7 % | — | 0.0 % | 0.0 % | 11.4 | 58.4 % | 19.2 % | — |
| DOMO Domo Inc | — | -28 % | 20 3/25 | Stage 4 | C 47 | 4 of 9 | 0.2 $ | Software - Application | – | — | — | Technology | 3.70 $ | -73.4 % | -67.9 % | -77.6 % | −86.8 % | +77.6 % | 2 | 42 | 18.3 % | 12.0 % | 1.80 | — | 0.0 | 0.5 | — | 830.0 | — | -6.3 | — | 74.9 % | -17.4 % | 0.0 % | -10.5 % | — | — | +0.6 % | — | 0.0 % | 0.0 % | -33.1 | 65.1 % | 8.5 % | — |
| HRTX Heron Therapeuti | 08/14 | -22 % | 29 3/22 | Stage 4 | D 29 | 3 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 0.50 $ | -67.8 % | -66.0 % | -71.3 % | −82.2 % | +387.8 % | 2 | 42 | 7.0 % | 8.8 % | 1.65 | — | 46.9 | 0.6 | — | — | — | 35.0 | — | 62.8 % | -20.5 % | -2,408.9 % | -2.7 % | — | — | +7.4 % | — | 0.0 % | 0.0 % | -19.6 | 83.3 % | 28.2 % | — |
| CDLX Cardlytics Inc | 08/05 | -32 % | 75 7/24 | Stage 4 | D 38 | 3 of 9 | 0.0 $ | Advertising Agencies | – | — | — | Communication Services | 3.70 $ | -53.6 % | -60.1 % | -81.7 % | −22.3 % | +116.3 % | 2 | 13 | 7.3 % | 9.4 % | 0.62 | — | 36.5 | 0.1 | 1.6 | 3.6 | — | -7.7 | — | 47.5 % | -44.8 % | -356.0 % | -7.7 % | -52.47 | — | -16.2 % | — | 0.0 % | 0.0 % | -14.8 | 29.9 % | 13.1 % | — |
| CVKD Cadrenal Therapeutics, Inc. Common Stock | 08/10 | -29 % | 82 7/22 | Stage 4 | D 33 | 1 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 2.00 $ | -54.9 % | -59.0 % | -80.7 % | −80.5 % | +867.4 % | 2 | 42 | 15.8 % | 11.5 % | 1.75 | — | 0.0 | — | 3.7 | — | — | 0.2 | — | — | 0.0 % | -300.6 % | -139.2 % | — | — | — | — | 0.0 % | 0.0 % | -66.0 | 6.0 % | 2.8 % | — |
| DFDV DeFi Development Corp. | 08/13 | — | 16 2/22 | Stage 4 | D 33 | 2 of 9 | 0.1 $ | Asset Management | – | — | — | Financial Services | 2.60 $ | -44.4 % | -45.3 % | -82.2 % | −92.3 % | +136.8 % | 2 | 42 | 10.8 % | 9.6 % | -4.06 | — | 0.0 | 5.4 | 7.7 | — | — | 2.4 | — | 97.5 % | 0.0 % | -2,398.4 % | -47.4 % | 12.54 | — | +442.3 % | — | 0.0 % | 0.0 % | -2.6 | 15.1 % | 28.4 % | — |
| ELTX Elicio Therapeutics Inc. | 08/06 | -20 % | 57 5/22 | Stage 1 | E 22 | 3 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 2.80 $ | -48.4 % | -51.2 % | -71.5 % | −76.6 % | +433.3 % | 2 | 42 | 34.2 % | 18.0 % | 1.79 | — | 0.0 | — | 99.1 | — | — | -2.6 | — | — | 0.0 % | -1,076.3 % | -92.4 % | -9.98 | — | -100.0 % | — | 0.0 % | 0.0 % | -41.0 | 17.0 % | 14.8 % | — |
| GAMB Gambling.com Group Ltd | 08/13 | -26 % | 44 6/31 | Stage 4 | D 35 | 4 of 9 | 0.1 $ | Gambling | – | — | — | Consumer Cyclical | 1.90 $ | -59.2 % | -59.4 % | -97.6 % | −82.3 % | +151.3 % | 2 | 80 | 4.8 % | 6.6 % | 0.73 | — | 17.7 | 0.4 | 0.6 | 27.2 | — | 9.5 | — | 88.4 % | -27.4 % | -35.6 % | 6.0 % | 1.13 | — | +30.1 % | — | 0.0 % | 0.0 % | 3.6 | 40.2 % | 9.3 % | — |
| PROP Prairie Operating Co. | 08/11 | -28 % | 30 1/10 | Stage 4 | C 50 | 4 of 9 | 0.1 $ | Oil & Gas E&P | Neutral | — | Energy | 0.71 $ | -61.2 % | -58.6 % | -76.9 % | −83.9 % | +382.1 % | 2 | 42 | 11.1 % | 10.1 % | -0.95 | — | 1.0 | 0.2 | — | 0.1 | — | 3.6 | — | 70.5 % | -37.9 % | -49.0 % | 6.6 % | — | — | +2,943.8 % | — | 0.0 % | 0.0 % | 0.5 | 20.5 % | 16.2 % | — | |
| PSQH PSQ Holdings Inc. | 08/11 | -33 % | 20 3/25 | Stage 4 | C 45 | 4 of 9 | 0.0 $ | Software - Application | – | — | — | Technology | 4.10 $ | -56.7 % | -64.3 % | -86.5 % | −86.4 % | +1,053.8 % | 2 | 42 | 7.5 % | 8.0 % | 0.44 | — | 0.0 | 0.5 | — | — | — | -3.8 | — | 63.2 % | -165.6 % | -170.8 % | -29.4 % | — | — | -21.6 % | — | 0.0 % | 0.0 % | -8.8 | 15.6 % | 0.0 % | — |
| SPWR Complete Solaria, Inc | 08/12 | -32 % | 83 8/25 | Stage 4 | D 42 | 3 of 9 | 0.0 $ | Solar | – | — | — | Technology | 0.30 $ | -59.9 % | -62.4 % | -80.8 % | −72.5 % | +658.1 % | 2 | 5 | 9.8 % | 10.1 % | 0.65 | — | 0.0 | 0.2 | 0.5 | — | — | 7.3 | — | 49.8 % | -15.3 % | 0.0 % | -12.9 % | -2.76 | — | +175.9 % | — | 0.0 % | 0.0 % | -4.1 | 21.6 % | 13.4 % | — |
| ADCT ADC Therapeutics SA | 08/11 | -15 % | 28 3/22 | Stage 4 | D 41 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.10 $ | -67.4 % | -70.8 % | -62.1 % | −79.1 % | +380.8 % | 1 | 42 | 8.7 % | 10.5 % | 1.88 | — | 0.0 | 1.8 | 3.6 | — | — | -1.4 | — | -26.3 % | -173.0 % | -705.5 % | -22.7 % | -0.54 | — | +14.9 % | — | 0.0 % | 0.0 % | -13.1 | 67.6 % | 5.6 % | — |
| GOSS Gossamer Bio Inc | 08/04 | -29 % | 89 8/22 | Stage 4 | C 48 | 3 of 9 | 0.1 $ | Biotechnology | Uses AI | — | Healthcare | 0.17 $ | -94.5 % | -95.2 % | -91.7 % | −95.7 % | +2,168.2 % | 1 | 42 | 11.9 % | 13.1 % | 2.05 | — | 0.0 | 1.5 | 2.7 | — | — | -0.4 | — | 100.0 % | 0.0 % | -783.4 % | -52.3 % | -1.26 | — | -57.7 % | — | 0.0 % | 0.0 % | -40.3 | 75.2 % | 11.7 % | — | |
| CRMT Americas Car-Mart Inc | 07/02 | -32 % | 33 5/31 | Stage 4 | D 32 | 2 of 9 | 0.0 $ | Auto & Truck Dealerships | Neutral | — | Consumer Cyclical | 3.20 $ | -84.7 % | -90.3 % | -92.9 % | −94.0 % | +427.7 % | 1 | 98 | 27.8 % | 22.0 % | 1.31 | — | 28.3 | 0.0 | 0.1 | 0.4 | 0.69 | 40.9 | — | 44.9 % | -7.0 % | -18.2 % | 0.9 % | 1.99 | — | -0.2 % | — | 0.0 % | 0.0 % | 9.2 | 87.7 % | 29.8 % | — | |
| ARAI Arrive AI Inc. | 08/13 | — | 35 4/25 | Stage 4 | D 37 | 3 of 9 | 0.0 $ | Scientific & Technical Instruments | Sells AI | — | Technology | 0.24 $ | -83.3 % | -93.6 % | -97.0 % | −97.0 % | +1,182.1 % | 1 | 42 | 9.6 % | 11.1 % | — | — | 0.0 | 110.0 | 4.8 | — | — | 0.0 | — | 100.0 % | 0.0 % | -398.1 % | -68.7 % | 3.71 | — | — | — | 0.0 % | 0.0 % | -10.2 | 2.5 % | 3.8 % | — | |
| FBLG FibroBiologics, Inc. Common Stock | 07/30 | — | 57 5/22 | Stage 4 | D 26 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.70 $ | -83.3 % | -83.2 % | -94.5 % | −81.5 % | +1,749.3 % | 1 | 42 | 10.3 % | 8.7 % | 1.17 | — | 0.0 | — | 1.6 | — | — | 0.0 | — | — | 0.0 % | -754.8 % | -123.7 % | 0.95 | — | — | — | 0.0 % | 0.0 % | -48.1 | 12.5 % | 2.8 % | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Weak 3-month RS (≤ 10) and falling today — negative momentum.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 77 stocks pass this scanner's criteria (as of 3. August 2026).
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
- Altman Z: Distress Zone
- Bankruptcy Study: Stacked Warning Signals
- Below the 50- & 200-SMA
- Beneish M-Score
- Going Concern (Distress Proxy)
- Insolvency Radar: Cash Running Low
- Kathy Donnelly: Liquid Movers Down
- Mike Webster: Overextended (Webby RSI)
- Near 52-Week Low
- Pradeep Bonde: $ Breakout Bearish
- Pradeep Bonde: 4% Breakout Bearish
- Qullamaggie: Parabolic (Short-Watch)
- RS Weakness (≤10)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Thomas Insolvency Candidate
- Weakness Cluster
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.